The pathological changes and clinical features of acute myelogenous leukemia and chronic myelogenous leukemia. 急性髓性白血病及慢性髓性白血病的病理改变及临床表现(七年制学生自学)。
Expression and regulation of Bim protein in chronic myelogenous leukemia 慢性粒细胞性白血病中Bim蛋白表达及调控研究
The drug blocks a mutant protein that causes chronic myelogenous leukemia ( CML ), becoming the first chemotherapy to specifically target cancer cells. 该药可以阻断引起慢性髓细胞性白血病(CML)的突变蛋白,成为第一个特异靶向癌细胞的化学药。
Application of BCR-ABL in chronic myelogenous leukemia BCR-ABL探针在慢性粒细胞白血病(CML)中的应用
Objective To examine the expression levels of P16 in the patients with chronic myelogenous leukemia ( CML ), and evaluate the pathogenesis and clinical significance of P16 in CML. 目的检测细胞周期调控因子P16在慢性粒细胞性白血病(CML)患者中的表达,探讨P16在CML中的作用机制及临床意义。